Cannabis investors bet on regulatory softening

By Emma Boyde

Rahul Bhushan, co-founder of the company behind the Rize Medical Cannabis and Life Sciences Ucits ETF, can be a master of understatement. “It wasn’t the easiest product to construct,” he says of the exchange traded fund, which launched in February 2020.

He and the team at RizeETF had been watching the legal cannabis sector since 2016, after becoming convinced of the potential returns from pharmaceutical applications if regulators acquiesced and allowed investment in the industry.

To read more:

Leave a Reply

Your email address will not be published. Required fields are marked *